Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
RAR-related orphan receptor gamma | 6 | 0 | 0 | 6 |
GLI family zinc finger 3 | 5 | 0 | 0 | 5 |
AR protein | 9 | 0 | 0 | 9 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
retinoic acid nuclear receptor alpha variant 1 | 5 | 0 | 0 | 5 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
estrogen nuclear receptor alpha | 7 | 0 | 0 | 7 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
activating transcription factor 6 | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
Histone H2A.x | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
lamin isoform A-delta10 | 4 | 0 | 0 | 4 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Chain A, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
Chain B, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
Chain A, ADP-dependent glucokinase | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, phosphodiesterase-nucleotide pyrophosphatase | 0 | 1 | 0 | 1 |
Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
Chain B, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 8 | 0 | 0 | 8 |
estrogen-related nuclear receptor alpha | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
Alcohol dehydrogenase E chain | 0 | 1 | 0 | 1 |
Alcohol dehydrogenase S chain | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 1 | 2 |
Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 0 | 0 | 1 |
Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 0 | 0 | 1 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 2 |
GTP:AMP phosphotransferase AK3, mitochondrial | 0 | 0 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 1 | 3 |
Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 2 |
P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 1 |
Adenylate kinase 2, mitochondrial | 0 | 0 | 0 | 1 |
Glycine--tRNA ligase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 2 |
Adenosine deaminase-like protein | 0 | 0 | 0 | 1 |
Protease | 0 | 1 | 1 | 2 |
P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 1 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 2 | 2 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
geminin | 3 | 0 | 0 | 3 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 3 | 3 | 6 |
Androgen receptor | 0 | 4 | 0 | 4 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 2 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
GLS protein | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 5 | 0 | 0 | 5 |
EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 2 | 0 | 0 | 2 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 7 | 0 | 7 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 2 | 0 | 3 | 0 | 4 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Integrin beta-3 | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 0 | 1 | 0 | 1 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 1 | 1 | 4 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
endonuclease IV | 1 | 0 | 0 | 1 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
Succinyl-diaminopimelate desuccinylase | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
progesterone receptor | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Spike glycoprotein | 3 | 0 | 0 | 3 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
Glutamine synthetase | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Amino acid transporter | 0 | 2 | 0 | 2 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
TDP1 protein | 3 | 0 | 0 | 3 |
G | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 1 | 3 |
Interferon beta | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 6 |
Neprilysin | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 1 | 3 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 1 | 3 |
Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 1 | 3 |
Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 1 | 3 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 2 | 1 | 5 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 1 | 3 |
Squalene synthase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 0 | 1 | 3 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 1 | 3 |
Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 3 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Chain A, Antigen Cd11a (p180) | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Integrin beta-2 | 0 | 1 | 0 | 1 |
Intercellular adhesion molecule 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Insulin receptor | 0 | 1 | 0 | 1 |
Integrin alpha-L | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 8 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
Glutamate 5-kinase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |